Rroji Merita, Eloot Sunny, Dhondt Annemie, Van Biesen Wim, Glorieux Griet, Neirynck Nathalie, Vandennoortgate Nele, Liabeuf Sophie, Massy Ziad, Vanholder Raymond
Service of Nephrology, University Hospital Centre "Mother Teresa", Tirana, Albania.
Nephrology Section, Department of Internal Medicine, Ghent University Hospital, 0K12, De Pintelaan, 185, B9000, Ghent, Belgium.
J Nephrol. 2016 Feb;29(1):81-91. doi: 10.1007/s40620-015-0195-z. Epub 2015 Apr 10.
To our knowledge, there are no studies on advanced chronic kidney disease (CKD) analysing the impact of ageing on serum concentrations of uraemic toxins while adjusting for renal function. Knowledge of this feature, however, could influence prognostic assessment and therapeutic decision-making, e.g. about when to start dialysis or how intensive it should be. Indeed, the slowing down of metabolism with age may result in lower uraemic toxin concentrations, hence reducing their toxic effects. In this case, a later start of dialysis or less intensive dialysis may become justified in an already fragile population that might enjoy a better quality of life without a survival disadvantage with conservative treatment. We assessed the impact of advancing age on uraemic solute concentrations [blood, urea, nitrogen (BUN), uric acid, creatinine, asymmetric and symmetric dimethylarginine (ADMA and SDMA), β2-microglobulin and a large array of protein-bound solutes] by matching 126 maintenance haemodialysis patients subdivided into two age-groups, younger vs. older (using the median as cut-off: 72 years). Concentrations were compared after age stratification and were matched with patient and dialysis characteristics. In addition, 93 non-dialysed CKD patients (median as cut-off: 70 years), with a comparable average estimated glomerular filtration rate (eGFR) between younger and older age-groups, were analysed. In haemodialysis patients, carboxy-methyl-furanpropionic acid (CMPF) levels were markedly higher and BUN and uric acid borderline lower in the older age-group. All other solutes showed no difference. At multifactor analysis, the concentration of several uraemic toxins was associated with residual renal function and protein intake in the overall haemodialysis group and the younger group, but the association with most solutes, especially those protein-bound, was lost in the older age-group. No differences were found in non-dialysed CKD patients. It was concluded that in this CKD population concentrations of uraemic toxins did not change substantially with calendar age.
据我们所知,目前尚无关于晚期慢性肾脏病(CKD)的研究在调整肾功能的情况下分析衰老对尿毒症毒素血清浓度的影响。然而,了解这一特征可能会影响预后评估和治疗决策,例如何时开始透析或透析强度应该多大。事实上,随着年龄增长新陈代谢减缓可能导致尿毒症毒素浓度降低,从而减轻其毒性作用。在这种情况下,对于本就脆弱的人群而言,推迟开始透析或采用强度较低的透析可能是合理的,这样他们可能在接受保守治疗时能享有更好的生活质量且不会有生存劣势。我们通过将126例维持性血液透析患者分为两个年龄组(年轻组与老年组,以72岁为中位数作为分界点)进行匹配,评估了年龄增长对尿毒症溶质浓度[血液、尿素、氮(BUN)、尿酸、肌酐、不对称和对称二甲基精氨酸(ADMA和SDMA)、β2-微球蛋白以及大量蛋白结合溶质]的影响。在年龄分层后比较浓度,并与患者和透析特征进行匹配。此外,还分析了93例未透析的CKD患者(以70岁为中位数作为分界点),其年轻组和老年组之间的平均估计肾小球滤过率(eGFR)相当。在血液透析患者中,老年组的羧甲基呋喃丙酸(CMPF)水平明显更高,BUN和尿酸略低。所有其他溶质均无差异。在多因素分析中,在整个血液透析组和年轻组中,几种尿毒症毒素的浓度与残余肾功能和蛋白质摄入量有关,但在老年组中与大多数溶质(尤其是蛋白结合溶质)的关联消失。在未透析的CKD患者中未发现差异。得出的结论是,在这个CKD人群中,尿毒症毒素浓度并未随日历年龄大幅变化。